Accumulation of microdamage in bone leads to the reduced strength of our skeleton. In health, bone adapts to the prevailing mechanical needs of the organism and is also capable of self-repair, sensing, removing and replacing damaged or mechanically insufficient volumes of bone. In disease and old age these characteristics are reduced. In order to undertake both of the processes of functional adaptation and repair the bone resorbing and forming cells must be very accurately targeted to areas of physiological need. The mechanism by which cells are precisely targeted to areas requiring repair is both clinically relevant and poorly understood. The osteocyte has been assumed to play a role in sensing damage and signaling for its removal, due largely to its abundance throughout the mineralized bone matrix. However, until recently there has been little evidence that osteocyte function is modified in the vicinity of the microdamage. Here I outline the possibility that the targeted removal of bone containing microcracks might involve signals derived from the apoptotic death of the osteocyte. I shall discuss data that support or refute this view and will consider the possible molecular mechanisms by which controlled cell death might contribute to the signals for repair in the light of work involving cells in bone and other tissue systems.
Introduction
Microdamage occurs in our bones as a result of repetitive cyclic loading incidents. Small cracks accumulate in the mineralised matrix of bone (Frost, 1960a) (Reilly and Currey, 2000) in a broadly mechanical load dependent manner (Schaffler et al., 1989) . The result is that in a set time interval an increased number of cracks will be engendered in the load bearing bones of individuals who undertake high impact exercise than in those that are relatively sedentary (Devas, 1961; Brukner et al., 1966; McBryde, 1975; Cline et al., 1998; Nunamaker et al., 1990) . This phenomenon is common to any load bearing material subjected to repetitive stresses that are high but lower than failure stress. However, unlike most engineering materials bone is capable of removing accumulating microdamage through the targeted action of its effector cells (osteoclasts and osteoblasts) (Burr et al., 1985; Burr and Martin, 1993; Mori and Burr, 1993; Burr, 2001; Parfitt, 2001 ). Unfortunately there appears to be an age and gender related accumulation of microdamage in our load bearing bones (Schaffler et al., 1995a) . These observations are consistent with the existence of a mechanism by which damage is targeted in bone and also to the development of an age related lesion in this mechanism. While it has been recognised for some time that there must be a method by which damage is sensed and targeted for removal by osteoclastic activity (Frost, 1985) our understanding of the cellular and molecular mechanisms involved in this process are poor. In addition, the reasons for the impairment of the targeting system with subject age are largely unknown.
Here we will discuss more recent findings which point to the role of the osteocyte and more specifically the apoptotic death of these cells in the mechanism by which osteoclasts sense and target damage in bone.
Apoptosis -'Death before Dishonour'
The identification of apoptotic cell death as an energy-dependent, non-immunogenic (non-phlogistic) and potentially controllable process has completely changed the way that we view cell destruction. It is clear to us now that the death of a cell does not necessarily signify a problem in a body system since it may occur as an entirely normal "healthy" component of the lifetime repertoire of a cell or tissue. It may also occur as a strategic response to a stimulus that may engender damaging effects in the future such as those modifying our genetic material (Evan and Littlewood, 1998) or to restrict the locality of specific cell phenotypes through adhesion receptor/ligand interactions, (known as anoikis) (Frisch and Francis, 1994; Frisch et B Noble Bone microdamage and apoptosis al., 1996) . Biologists have only recently become accepting of an essentially wasteful system in which cells willingly undergo suicide in the interest of the whole organism. But apoptosis should not simply be viewed as the deletion of cells since the death process gives rise to a large and expanding number of potent signal molecules that dramatically affect the behaviour of cells in the vicinity of the deletion and potentially far beyond. The process of apoptosis involves an orchestrated cell shrinkage, retention of organelles, chromatin condensation and margination, nuclear membrane changes, protein fragmentation, cell membrane modification and cleavage of DNA often into inter-nucleosomal size increment fragments (Wyllie et al., 1980) . This is followed by packaging of the cell's cytoplasmic and nuclear contents into membrane bound vesicles with specific membrane surface molecular signatures which allow their rapid removal from the system by specialist and amateur phagocytic cells (for review see Hengartner, 2000) . The packaging of cellular contents into vesicles (apoptotic bodies) and their rapid removal from the system allows apoptosis to occur with minimal or no associated inflammatory response. Central to the initiation and execution of the apoptotic cascade are a number of enzymes that contribute to the demolition of specific cellular components and structures, destruction of inhibitors of apoptosis and activation of stimulators of the same. The most prominent of these are cysteine proteases of the caspase family. At least 8 of these enzymes are involved in the apoptotic process including the production of the signature morphological changes (for review see Hengartner, 2000) .
The morphological criteria describing apoptosis remain the only certain evidence of an apoptotic death. Many of the biochemical and molecular changes such as caspase activation, DNA ladders, phoshatidylserine exposure and membrane integrity may also present to a lesser extent during necrosis. For this reason they should be used as a method of apoptosis identification only in combination and preferably along with a morphological test.
Necrosis is the alternative method of cell death involving cell swelling and bursting which results in spillage of cell contents and (see Figure 1 ) related initiation of an inflammatory response via neighbouring cell types and cells of the immune system (Wyllie et al., 1980; Wyllie, 1997) . Necrosis is not energy dependent, is rapid and not as susceptible to control as apoptosis. Thankfully it is not as common as apoptosis which accounts for the vast majority of the estimated 10 billion cell deaths that occur daily in a healthy individual (Heemels, 2000) .
Cells are removed specifically and efficiently when they are supernumerary, damaged or misplaced. For example cells undergo apoptosis upon experiencing moderate levels of physical injury or infection (Martin, 2001; Dockrell, 2001; Grassme et al., 2001) , after initiation of oncogenic transformation (Nguyen-Ba and Vasseur, 1999; Compagni and Christofori, 2000) radiation induced damage (Kulms and Schwarz, 2002) , as a result of removal of nutrients (Hogg et al., 1999) , growth factors or hormones key to their function (Fraser et al., 1996; Pelengaris and Evan, 1997; Deckwerth et al., 1998; Monroe et al., 2000; Tesarik et al., 2002) , or when they have been developmentally programmed for removal during tissue morphogenesis (Meier et al., 2000) . In addition, some cells die by apoptosis as a normal response to having finished a time or activity limited bout of differentiated function (Adams and Shapiro, 2002) , to maintain or modify the size/shape of organs and simply to counter the huge number of cell mitoses in the adult organism (i.e., turnover at the cellular and tissue level) (Kerr et al., 1972) .
Clearly the ultimate outcome of cellular apoptosis is the death of a cell resulting in the removal of the cell, it's genetic material and associated activities from a tissue. However, the cell does not disappear without potentially having profound effects on neighbouring cell types who are often recruited in the removal of the apoptotic vesicles or which might rarely undergo 'bystander apoptosis' (Andrade-Rozental et al., 2000; Ripps, 2002; Sanson et al., 2002) .
Macrophages are the professional phagocytes in our bodies. They respond differently to the ingestion of an apoptotic cell vesicle than to necrotic cell debris. While necrotic cell material engenders the production of pro-inflammatory cytokines such as TNF-α by the phagocyte, the same cell will produce anti-inflammatory molecules such as TGF-β1, PGE-2 and IL-10 and induce macrophage release of thromboxane B2 (Voll et al., 1997; Fadok et al., 1998 Fadok et al., , 2000 , upon encountering and ingesting an apoptotic body . The result is that apoptosis is not simply non-stimulatory to the immune system but is also inhibitory to it. A specific system of apoptotic cell recognition must exist.
The cell membrane of the apoptotic cell is known to expose a range of molecules that are thought to constitute a unique "apoptotic" signature recognised by phagocytic cells. These include a loss of phospholipid asymmetry (Fadok et al., 2001) , expression of the adhesion molecule ICAM-3 (Moffatt et al., 1999; Gregory, 2000) surface sugars (Duvall et al., 1985; Dini et al., 1992) ), and oxidised phospholipid surface structures (Chang, 1999) . Thrombospondin, complement components and b(2) glycoprotein I contribute to the process in some way by bridging the phagocyte and apoptotic-cell surfaces (Stern et al., 1996) .
In addition, receptors and ligands on the phagocyte surface have been implicated in the recognition and engulfment of apoptotic cells. These include lectins (Ii et al., 1990; Beppu, 2001) , scavenger receptors (Kulms and Schwarz, 2002) , the ATP-binding cassette transporter 1 (ABC1) (Luciani and Chimini, 1996; Wu and Horvitz, 1998; Hamon et al., 2000) , integrins (Stern et al., 1996; Rubartelli et al., 1997 ) the lipopolysaccharide (LPS) receptor CD14 (Gregory, 2000) and complement receptor (CR)3 and CR4 (Mevorach et al., 1998; Taylor et al., 2000) . The role and function served by these receptors and the exact molecular pairings required for function are largely unknown.
Disruption of this complex system of cell removal leads to a small number of significant disease states and developmental abnormalities such as systemic lupus erythematosus (SLE) and Behcet's disease (Yang et al., 2002) . But, there is a high level of redundancy in the apoptotic system, such that disruption of many key molecular elements in the process (e.g., some caspases) fails to engender a phenotype (Ueki et al., 2002) . Overall then apoptosis is important to the health of our bodies is often enhanced during disease and injury and is relatively difficult to abolish.
Bone and Apoptosis
In theory bone is potentially unique with regard to its ability to withstand loss of cells particularly the matrix bound osteocytes. Unlike soft tissues the loss of significant numbers of cells in bone will not have an immediate impact on the size and mechanical function of the tissue. In the medium term profound changes in bone function would almost certainly ensue but this tissue would seem to be an ideal site for showcasing the signalling power of apoptosis. Could apoptosis play a role in targeted remodelling in bone?
The causes and outcome of microdamage.
High impact, intensive exercise has been shown to engender microdamage in bones. For example, significant levels of microdamage can be found in the ribs of rowers (Warden et al., 2002) , the long bones of race horses (Norrdin et al., 1998) , the leg experiencing the highest loads in greyhounds running on oval tracks in a common direction (Muir et al., 1999; Tomlin et al., 2000) and associated with the 'march fractures' of army recruits undertaking intensive training (McBryde, 1975) . However it has also been shown that strains magnitudes of 1500 µstrains which equate to osteogenic levels of exercise (Burr et al., 1996) are sufficient to cause microdamage within 10,000 cycles (Burr, 2001 ) and predicted to causes stress failure at 10 5 cycles (Taylor, 1998) . In addition several studies have shown strong relationships between increased age of an individual and exponential increase in crack density (Schaffler et al., 1995a) .
Accumulation of microdamage has been shown to reduce the strength of bones. While the existence of microdamage in a bone appears to decrease its stiffness probably due to dissipation of energy, the overall strength or force to failure can be reduced dramatically (Carter and Hayes, 1977) . This phenomenon clearly has direct clinical relevance.
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Bone microdamage and apoptosis
Targeted removal of microdamage?
It has been suggested that removal of microdamage in bone is not achieved through a 'random' stochastic remodelling process alone but that damage is actively targeted for removal by the osteoclast population (Burr and Martin, 1993; Parfitt, 2001 ). Evidence to support this hypothesis has been produced by the group of Burr in which they found that osteoclastic activity was over represented at sites of microdamage (Burr et al., 1985; Mori and Burr, 1993) . Recent experiments demonstrating the time dependent migration of osteoclasts into regions of cortical bone containing experimentally induced microdamage in rats have strengthened the argument for the targeting of damage in bone (Verborgt et al., 2000; Noble et al., 2003) . Coupled with the knowledge that high levels of microdamage can increases fracture risk these data point to the importance of the bone effector cell targeting system in the maintenance of bone health.
How does the targeting system work?
The mechanism by which microdamage is targeted in bone is unknown as is the reason for its loss under conditions of ageing and disease. We might find clues as to the mechanism by examining the changes in bone cell behaviour known to be associated with conditions under which the targeting system is lost or impaired (Figure 2) .
In this regard, while targeting of damage appears to be sufficient for maintenance of strength in healthy bone, osteoclast targeting of damage does not appear to work efficiently in older individuals (Frost, 1960a; Wong et al., 1985; Schaffler et al., 1995a,b; Norman and Wang, 1997; Mori et al., 1997) . More specifically damage is not efficiently removed from interstitial volumes which are representative of older regions of bone (Wong et al., 1985) . Accumulation of microdamage is higher in females than males and there is a particularly marked increase in women over the age of 40 years (Schaffler et al., 1995a) . High doses of bisphoshonates also reduce the removal of microdamage Mashiba et al., 2000; Li et al., 2001; Mashiba et al., 2001) due to their obvious inhibitory effects on osteoclast function.
The reasons for the enhanced accumulation of microdamage under these circumstances is not entirely clear but is likely to be due to one of two broadly defined changes in the bone. Firstly, a change in the material properties of the bone that leads to accumulation of damage that is beyond the scope of the repair system. Secondly a problem with the cells involved in the sensing, signalling and/or repair of the bone. In fact it is likely that both of these changes contribute to the accumulation of damage but overall, that any changes in the material properties of the bone will not occur entirely independently of changes in the cell population that create, remodel and maintain it.
Cell behaviour is likely to represent a significant contributory factor in this phenomenon. Cells might lose their ability to produce the stimulus, their sensitivity to the targeting stimulus or their ability to respond to it, or there may be changes in detailed cell function such as synthesised collagen composition, resorptive enzyme activities or their numbers in bones.
Age related changes in the behaviour and dynamics of bone cell populations are likely numerous and to a large extent understudied. Gaining an understanding of altered cell behaviour is difficult since it appears that after a prepubertal period of longitudinal growth our bones spend a number of years expanding in width (late teens through 20's) only to embark on a slow but largely unavoidable loss of material from the age of 30 yrs onwards (Parfitt, 1994) . Not only does this mean that there is never really a "steady state" situation within which to describe the 'normal' compliment and activity of cells in bone but also that it is unlikely that remodelling ever functions merely to remove and accurately replace an existing piece of bone. A state of disequilibrium exists.
The postmenopausal reduction in circulating oestrogen levels is associated with increased rates of bone turnover and bone loss due to a relatively high activity and numbers of both osteoblasts and osteoclasts with a functional imbalance in favour of the osteoclasts (Rosen, 2000) . The large increase in osteoclastic activity that occurs after withdrawal of oestrogen is transient and activity returns to levels close to those in oestrogen-replete individuals with time (Lane et al., 1998; Tremollieres et al., 2001 ). The increased osteoclast activity would tend to coincide with the occurrence of increased numbers of microcracks in these individuals although the detailed timing of the two phenomenon has not been compared.
Changes in the numbers and activity of bone cells with ageing is less clearly understood possibly due to the unfortunate decreased popularity of histomorphometric studies in bone research. Studies have variously described significant increases or decreases with age (Gruber et al., 1986; Rodan and Martin, 2000; Chan and Duque, 2002) . Overall, it would seem fair to suggest that osteoblast activity is likely reduced and that osteoclast activity is either increased or remains constant with age and that osteoblast function in the absence of osteoclastic activity cannot remove and Figure 2 . A signal must be produced near to the site of microdamage in order for osteoclast (OC) production from blood vessel (BV) derived osteoclast progenitors (OP) to be initiated in a site-specific manner. Secondary signals may be derived from osteoblasts (OB), which are thought to vacate the bone surface prior to resorption.
replace microdamage although more precise study is required in this field.
Clearly, there is not a consistent and obvious problem with generalised osteoclastic function associated with an increased occurrence of cracks, perhaps supporting the notion that it is targeted osteoclast activity that is important in the removal of microdamage. It is possible that any lesion is associated with the cells that are sensing the damage. The site of the damage-sensor in bone is not clear but the matrix bound osteocytes are favoured since they are the only cells consistently to be found in close association with damage.
The Osteocyte
The osteocyte is formed from a differentiated osteoblast that is present on an active bone-forming surface and which has for a particular but unknown reason ceased production of bone matrix. In doing so, it falls behind its neighbours who are advancing with the newly formed bone surface while remaining in intimate contact with the advancing cells via long cellular projections (Marotti et al., 1998) . It becomes embedded in the bone matrix in a vacuole cushioned by fluid and large molecules with the appearance of glycosaminoglycans. Only one in approximately 12 osteoblasts undergo this radical change in behaviour and they are all sitting on a bone surface next to a cell which will not behave in this way. There must exist a highly controlled message that brings about the change in a very localised fashion. The behaviour does not appear to be an entirely genetically programmed 'patterning' response. Despite the fact that lacuna density does scale inversely with body size across species (Mullender et al., 1996a ) the density of lacunae is found to be variable not only between individuals (Tomkinson 1998) and with age (Mullender et al., 1996a) , but also under conditions of disease (Tomkinson 1998 ) and altered mechanical stimuli (Mullender et al., 1996b) .
There is no doubt that the osteocyte is responsive to load. The cells respond in vitro and in vivo to increased load induced strains by producing or modifying a number of important molecules such as activation of ion channels (Rawlinson et al., 1995) , upregulation of Fos gene expression (Inaoka et al., 1995) , nitric oxide Klein-Nulend et al., 1995) , prostocyclin production (Lanyon, 1992) , IGF-1 (Lean et al., 1995) and release of PGE-2 (Ajubi et al., 1996) , collagen I gene expression (Sun et al., 1995) , COX-2 (Matsumoto et al., 1998) , decreased glutamate transporter expression (Mason et al., 1997) and increased intracellular calcium (Rawlinson et al., 1995; Kawata et al., 1998) . However, few of these responses have been shown to be a requirement of the loading response at the level of the whole bone and none have been shown to be a required product of the osteocyte population specifically.
During ageing what happens to the osteocyte?
The long held view that the majority of osteocytes live for the entire life-span of an individual was based primarily on findings in the bone of the ear ossicle. Because viable osteocytes can be found in the ear ossicle and labyrinthine capsule of aged individuals and this bone was considered to experience little if any remodelling the osteocytes were believed to have been 'born' at the point of production of the bone. In fact it is true that the bone experiences only a little remodelling after the age of 1 year. However, the interpreters of this data have failed to acknowledge that the data also demonstrates that in individuals over 1 year of age 40-60% of osteocytes are already dead and that 90-95% of the cells are dead from age 30 years and older (Kakizaki and Altmann, 1971; Marotti et al., 1998) . The remaining 5-10% of cells that are viable could be the result of the small amount of remodelling that does occur on the surfaces of these bones. In the context of this article it will be important to remember that the lack of osteocytes in this bone coincides with a lack of remodelling activity. It has been clear for some time that the numbers of viable osteocytes in our bones decreases with age (Frost, 1960b; Dunstan et al., 1993) . It is likely that the majority of this age related decrease is occurring in the increasing proportion of older bone that is not being actively remodelled (i.e., the interstitial bone) in older individuals (Chan and Duque, 2002) .
Overall, the loss of osteocytes from our bones is associated with a generalised impairment of the damage repair system. Older people have more damage, more damage is found in older and less vital interstitial bone and importantly regions of bone with lower osteocyte lacuna density contain more damage (see above).
What is the nature of the signal?
If a micro-damage "targeting" signal is derived from the osteocyte we might expect to observe a change in osteocyte behaviour, which co-localises with damaged bone and with resorption sites.
The signal mechanism may involve either the gain of a pro-resorptive signal or the loss of an inhibitor of osteoclast function. Previous studies demonstrating increased accumulation of damage in regions of low osteocyte number (Mori et al., 1997) and illustrating reduced remodelling of bone devoid of live osteocytes in the ear ossicle (Marotti et al., 1998) , labyrinthine capsule (Kakizaki and Altmann, 1971) , transplanted bone in the rat (Kamijou et al., 1994) and human osteonecrotic bone (Kenzora et al., 1978) and production of a pro-osteoclastic signals form an osteocyte cell line (Zhao et al., 2002) all point to the greater likelihood of a pro-resorptive signal of osteocytic origin being involved. On the other hand a small number of studies have identified osteocyte cell fractions and osteocyte derived molecules with negative effects on osteoclast formation and function although the relevance of these data in vivo are as yet unclear (Maejima-Ikeda et al., 1997; Heino et al., 2002) .
Osteocyte apoptosis during induction of microdamage
Recently it has been demonstrated that induction of damage in bone is associated with an increase in osteocyte death by apoptosis. Large-scale osteocyte apoptosis has been associated with the cortical bone resorption induced by mechanical load engendered microdamage in a rat model of
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Bone microdamage and apoptosis fatigue fracture (Noble et al., 1997b; Verborgt et al., 2000; Noble et al., 2003) . Under healthy circumstances little if any intracortical remodelling occurs in rat long bones but if microdamage is generated in the cortical bone, osteoclasts enter the cortical bone to remove the damage. In both studies, damage was induced through overloading the bones (using cyclical loads at approximately 8000 µstrain) and osteoclastic invasion and osteocyte apoptosis was monitored on a spatial and temporal basis. A transient burst of osteocyte apoptosis at 7 days after damage induction was shown to precede osteoclastic invasion by several days (Noble et al., 2003) and to co-localise with regions of damaged bone (Verborgt et al., 2000) . At 14 days after damage induction the apoptosis had resulted in a reduction in live osteocyte numbers. However, resorbed bone was replaced by newly formed bone by 28 days after the damage-inducing incident. The increase in apoptosis at damage sites was associated with an increase in the proapoptotic molecule bax (Verborgt et al., 2000) . The fact that apoptosis was associated with regions of damage and that it preceded osteoclastic activity raises the possibility that the apoptotic event might actually represent the source of a signal used in targeted osteoclastic invasion. Recent evidence from other studies illustrates an association between situations of bone modelling and remodelling and osteocyte apoptosis. Apoptotic osteocytes are more common in young growing bone experiencing a high degree of resorption than in relatively quiescent normal adult human bone (Noble et al., 1997b) . The increase in bone turnover induced during a medical menopause is associated with an increase in the proportion of apoptotic and dead osteocytes in human bone (Tomkinson et al., 1997) and similar increases could be prevented through the addition of 17β-estradiol in ovarectomised rats (Tomkinson, 1998) . Studies have shown that glucocorticoid induced bone loss in the mouse and human is associated with increased osteocyte apoptosis (Weinstein et al. 1998 (Weinstein et al. , 2000 . In contrast, a study in the rat was unable to demonstrate increased apoptosis of osteocytes after glucocorticoid treatment (Silvestrini et al., 2000) and might be of relevance to the known species specific responses to these compounds. There is also other evidence of co-localisation of the osteocyte apoptosis and osteoclastic resorption. In a rat model of bone loading, the proportion of apoptotic osteocytes present in the ulna cortex adjacent to a known resorption site was halved after a period of loading that resulted in switching off the resorption site (days (Noble et al., 2003) ). By loading these bones both osteocyte apoptosis and bone resorption were switched off in the same region of bone. Furthermore, in this model apoptotic osteocytes were more common in regions of bone experiencing very low peak strain magnitudes.
All of these situations of high apoptosis involve high levels of bone (re)modelling and in particular resorption. These observations would tend to suggest that osteocyte apoptosis plays a role in the normal bone turnover process itself, that oestrogen is an important determinant of osteocyte viability and that strain also acts as a survival factor in bone. The possibility that loading affects osteocyte viability is backed up by experiments ex-vivo in which loading of rat bones in culture increased viability of the osteocytes (Lozupone et al., 1996) .
The appearance of osteocyte apoptosis in bone that is undergoing turnover and more specifically increased resorption poses the question as to the identity of molecular links between the two processes. In other cell types, apoptosis involves the production of signal molecules that initiate the removal of the cell by phagocytosis. The cells undertaking the phagocytosis are often not 'professional phagocytes' but can be neighbouring cells. Since only the osteoclast could efficiently remove apoptotic osteocytes in mineralised matrix, it is possible that signals produced by apoptotic cells may influence osteoclast formation and/or function -either directly or indirectly. The search for the identity of such molecules is underway.
The mechanism of initiation of apoptosis by microdamage might be related to either mechanically sensitive signalling pathways or direct physical damage to either the cells or the lacuna/canalicular system that supplies them with nutrients and oxygen.
Both epithelial and cardio-myocyte cells are known to respond to high levels of stretch by undergoing apoptosis engendered through the induction of P53, angiotensin II and FAS-ligand (Leri et al., 1998; Wang et al., 1999) . On the other hand plasma membrane stress failure can lead to cell death. However, many cells display a remarkable capacity to survive membrane rupture through the its rapid repair by fusion of lysosomal vesicles (McNeill, 2002) and healthy muscle skeletal tissue may contain up to 30% wounded cells (McNeill and Steinhardt, 1997) . Further work is required to determine the mechanism by which microdamage induces osteocyte apoptosis.
The potential molecular links between damage induced apoptosis and targeted osteoclast activity are unknown and are the subject of research in our laboratories. However the identification of osteocyte apoptosis as a potential signal source has improved our chances of identifying the signals central to the targeted resorption process in bone and the design of methods of minimising or controlling the production of these signals.
